Ginossar Ventures

Illumex is a company focused on optimizing structured data for generative AI analytics while maintaining strong governance practices. It has developed a generative semantic fabric platform that analyzes metadata to discover and label data, enhancing it with semantic meaning and business context without altering the original information. The company's platform features a domain-specific AI engine that supports business users by providing trustworthy, customized organizational language models. This approach enables organizations to leverage Big Data for decision intelligence and promotes data democratization and trust. By contextualizing organizational knowledge, Illumex aims to enhance efficiency and return on investment for its clients.

GlossAI is a company that specializes in automatic content generation using artificial intelligence. It addresses the challenge of audience engagement by transforming long-form video content into concise, engaging highlight clips and various other formats, such as short videos and blog posts. This innovative platform allows organizations and individuals to efficiently edit and repurpose their pre-recorded content, enabling them to decide what to share and through which channels. By catering to the decreasing attention spans of modern audiences, GlossAI enhances the accessibility and consumption of content across multiple platforms.

DeepSurface is a cybersecurity company headquartered in Portland, Oregon, specializing in risk-based vulnerability management. It offers a platform that automates the analysis and prioritization of vulnerabilities for cybersecurity teams. Utilizing advanced rules and an extensive collection of over 50 environmental attributes, DeepSurface contextualizes vulnerabilities and their potential chains to predict areas of greatest risk for organizations. This enables teams to effectively prioritize their efforts and measure vulnerability risk with proven methodologies. Trusted by enterprise-level clients, DeepSurface aims to enhance the efficiency of cybersecurity operations by providing clear insights into where adversaries could inflict the most damage.

Yonalink operates a global network comprising over 30,000 medical centers. It specializes in real-time collection of clinical trial data through its platform, which streamlines electronic health records (EHR) to electronic data capture (EDC), employs AI-driven case report form (CRF) data mapping, and facilitates secure, automated migration of research data from health records. This service enhances trial efficiency, improves data quality, reduces staff burnout at medical centers, and expands access to novel patient care opportunities. Additionally, the platform enables management of clinical trial operations and vendors, accelerates drug and device development, promotes patient diversity and enrollment, and ensures secure, fast, and error-free data capture processes for healthcare providers and researchers.